share_log

Shareholders May Not Overlook Silk Road Medical Insiders Selling US$1.9m In Stock

Shareholders May Not Overlook Silk Road Medical Insiders Selling US$1.9m In Stock

股东们可能不会忽视丝绸之路医学内部人士出售190万美元股票
Simply Wall St ·  2023/11/17 05:41

While Silk Road Medical, Inc (NASDAQ:SILK) shareholders have enjoyed a good week with stock up 20%, they need remain vigilant. Although prices were relatively low, insiders chose to sell US$1.9m worth of stock in the past 12 months. This could be a sign of impending weakness.

尽管丝路医疗公司(纳斯达克股票代码:SILK)股东度过了愉快的一周,股价上涨了20%,但他们需要保持警惕。尽管价格相对较低,但内部人士选择在过去12个月中出售价值190万美元的股票。这可能是即将出现疲软的迹象。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

虽然我们绝不会建议投资者仅根据公司董事的所作所为做出决定,但逻辑要求你应该注意内部人士是在买入还是卖出股票。

View our latest analysis for Silk Road Medical

查看我们对丝绸之路医疗的最新分析

The Last 12 Months Of Insider Transactions At Silk Road Medical

丝路医疗过去12个月的内幕交易

Over the last year, we can see that the biggest insider sale was by the insider, Erica Rogers, for US$850k worth of shares, at about US$47.10 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The silver lining is that this sell-down took place above the latest price (US$8.21). So it is hard to draw any strong conclusion from it.

在过去的一年中,我们可以看到,最大的内幕交易是内部人士埃里卡·罗杰斯以价值85万美元的股票出售,每股约为47.10美元。虽然我们通常不喜欢看到内幕抛售,但更令人担忧的是销售是否以较低的价格进行。一线希望是,此次抛售高于最新价格(8.21美元)。因此,很难从中得出任何有力的结论。

Silk Road Medical insiders didn't buy any shares over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

丝路医疗内部人士去年没有购买任何股票。您可以在下表中看到过去一年的内幕交易(由公司和个人进行的)。点击下图,你可以看到每笔内幕交易的确切细节!

insider-trading-volume
NasdaqGS:SILK Insider Trading Volume November 17th 2023
纳斯达克证券交易所:Silk 内幕交易量 2023 年 11 月 17 日

I will like Silk Road Medical better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我看到一些大笔的内幕买入,我会更喜欢丝路医疗。在我们等待的同时,请查看这份免费名单,列出了最近有大量内幕买入的成长型公司。

Silk Road Medical Insiders Are Selling The Stock

丝绸之路医学内部人士正在出售股票

Over the last three months, we've seen significant insider selling at Silk Road Medical. In total, insiders dumped US$138k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.

在过去的三个月中,我们看到丝路医疗进行了大量的内幕交易。在那段时间内,内部人士总共抛售了价值13.8万美元的股票,我们没有记录任何买入记录。总的来说,这让我们有些谨慎,但这并不是万能的。

Does Silk Road Medical Boast High Insider Ownership?

丝绸之路医疗是否拥有很高的内部所有权?

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. From our data, it seems that Silk Road Medical insiders own 2.1% of the company, worth about US$6.6m. We do generally prefer see higher levels of insider ownership.

许多投资者喜欢检查公司有多少股份由内部人士拥有。通常,内部人所有权越高,内部人士被激励长期建立公司的可能性就越大。从我们的数据来看,丝路医疗内部人士似乎拥有该公司2.1%的股份,价值约660万美元。我们通常更愿意看到更高的内部所有权水平。

So What Do The Silk Road Medical Insider Transactions Indicate?

那么,《丝绸之路医疗内幕交易》表明了什么?

Insiders haven't bought Silk Road Medical stock in the last three months, but there was some selling. Looking to the last twelve months, our data doesn't show any insider buying. When you consider that most companies have higher levels of insider ownership, we're a little wary. So we're not rushing to buy, to say the least. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. At Simply Wall St, we've found that Silk Road Medical has 4 warning signs (1 is a bit concerning!) that deserve your attention before going any further with your analysis.

在过去的三个月中,业内人士没有买入丝绸之路医疗的股票,但有一些人抛售。展望过去的十二个月,我们的数据并未显示任何内幕买盘。当你考虑到大多数公司的内幕所有权水平更高时,我们会有点谨慎。因此,至少可以说,我们并不急于购买。虽然我们喜欢了解内部人士的所有权和交易情况,但在做出任何投资决定之前,我们也一定要考虑股票面临的风险。在 Simply Wall St,我们发现丝路医疗有 4 个警告标志(1 个有点令人担忧!)在进一步分析之前,这值得你关注。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

当然,通过寻找其他地方,你可能会找到一笔不错的投资。因此,来看看这份有趣的公司的免费清单吧。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发